Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

'New frontiers for fairer breast cancer care in a globalized world'

Map of world with faculty headshots


Dr Didier Verhoeven

Dr Didier Verhoeven is a medical oncologist working in AZ KLINA, Brasschaat, Belgium. He is Head of the Department of Medical Oncology and Hematology. 

He was a trainee of Professor AT. Van Oosterom and is currently Clinical Director of the “Breast Clinic Voorkempen” which treats nearly 300 new cases of breast cancer a year. (Accreditation by EUSOMA since 2015).

Dr Verhoeven defended his PhD thesis about breast cancer: “Tumor cell proliferation and stromal changes in breast cancer” at the University of Antwerp in 1992. In addition he obtained a Master degree in medical and pharmaceutical research at the University of Brussels.

He has written many papers as first author about oncology especially about breast cancer in international and national peer reviewed journals. He is member of many cancer societies and peer-reviewer of highly ranked medical journals. Although he is a real clinician, part of his work goes to data management and quality improvement programs. In 2014, he was appointed as guest professor medical oncology (topic: Quality in Oncology) at the University of Antwerp. In February 2015, he was the driving force and chair of the 5th International Congress of Breast Disease Centers in Antwerp. In 2018, Oxford University Press accepted his book: “Breast Cancer: Global Quality Care” for publication (14/11/2019 ) (co-editors: C.Kaufman, US, R.Mansel, UK and S.Siesling, The Netherlands; with extensive book review in ASCO-Post, 2020). In November 2019, he was the chair and local responsible for the organisation of the 3the International Oncology Leadership Conference in Antwerp. In May 2021, he was appointed as voting-member of the board of the National College of Clinical Experiments. In November 2021, he was asked to participate on the Breast Cancer Lancet Commission.


All members of the University and NHS clinical staff are welcome.

Please email Louise King if you would like to attend online.